Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 8, 2014, Pages 1434-1440

  Bonomo, Jason A ^a,e   Ng, Maggie C Y ^b,e   Palmer, Nicholette D ^b,e   Keaton, Jacob M ^e   Larsen, Chris P ^f   Hicks, Pamela J ^e   Langefeld, Carl D ^c,e   Freedman, Barry I ^d   Bowden, Donald W ^b,e  

^a Departments of Molecular Medicine and Translational Science   (United States)

^b Departments of Biochemistry   (United States)

^c Wake Forest Baptist Health   (United States)

^d Departments of Internal Medicine Nephrology   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f Nephropathology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; NEPHRIN; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; MEMBRANE PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; END STAGE RENAL DISEASE; EXOME; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETIC NEPHROPATHY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; PROTECTION; RISK ASSESSMENT; RISK FACTOR;

AFRICAN AMERICANS; AGED; APOLIPOPROTEINS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS;

EID: 84923798520     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00290114     Document Type: Article

References (24)

1. USRDS: USRDS Annual Data Report: Volume 2, Chapter 11, 367–382, 2010. Available at: http://www.usrds.org/2010/pdf/v2_11.pdf. Accessed May 29, 2012.
2. Spray BJ, Atassi NG, Tuttle AB, Freedman BI: Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 5: 1806–1810, 1995.
3. Freedman BI, Tuttle AB, Spray BJ: Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 25: 710–713, 1995.
4. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841–845, 2010.
5. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129–2137, 2011.
6. McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MC, Sale MM, Divers J, Langefeld CD, Freedman BI, Bowden DW: A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 79: 563–572, 2011.
7. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr., Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators: APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369: 2183–2196, 2013.
8. Palmer ND, Freedman BI: Insights into the genetic architecture of diabetic nephropathy. Curr Diab Rep 12: 423–431, 2012.
9. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1: 575–582, 1998.
10. Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac C K, Kashtan CE, Homberg C, Olsen A, Kestilä M, Tryggvason K: Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64: 51–61, 1999.
11. Lahdenkari AT, Kestilä M, Holmberg C, Koskimies O, Jalanko H: Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int 65: 1856–1863, 2004.
12. Philippe A, Nevo F, Esquivel EL, Reklaityte D, Gribouval O, Tête MJ, Loirat C, Dantal J, Fischbach M, Pouteil-Noble C, Decramer S, Hoehne M, Benzing T, Charbit M, Niaudet P, Antignac C: Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19: 1871–1878, 2008.
13. Santín S, García-Maset R, Ruíz P, Giménez I, Zamora I, Peña A, Madrid A, Camacho JA, Fraga G, Sánchez-Moreno A, Cobo MA, Bernis C, Ortiz A, de Pablos AL, Pintos G, Justa ML, Hidalgo- Barquero E, Fernández-Llama P, Ballarín J, Ars E, Torra R; FSGS Spanish Study Group: Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int 76: 1268–1276, 2009.
14. Cooke JN, Bostrom MA, Hicks PJ, Ng MC, Hellwege JN, Comeau ME, Divers J, Langefeld CD, Freedman BI, Bowden DW: Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrol Dial Transplant 27: 1505–1511, 2012.
15. Divers J, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Xu J, Langefeld CD, Freedman BI: Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: The African American-diabetes heart study. Diabetes Care 33: 131–138, 2010.
16. Keene KL, Mychaleckyj JC, Leak TS, Smith SG, Perlegas PS, Divers J, Langefeld CD, Freedman BI, Bowden DW, Sale MM: Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet 124: 147–154, 2008.
17. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89: 82–93, 2011.
18. Milliken J: Analysis of Messy Data. Volume 1: Designed Experiments, Van Nostrand Reinhold Publishing, Boca Raton, FL 1984, p 33.
19. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, Thomas G, Hoover R, Hunter DJ, Chanock S: Beyond odds ratios—communicating disease risk based on genetic profiles. Nat Rev Genet 10: 264–269, 2009.
20. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K: Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 17: 368–373, 2001.
21. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW: Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans. PLoS Genet 7: e1002150, 2011.
22. Welsh GI, Saleem MA: Nephrin-signature molecule of the glomerular podocyte? J Pathol 220: 328–337, 2010.
23. Fornoni A, Jeon J, Varona Santos J, Cobianchi L, Jauregui A, Inverardi L, Mandic SA, Bark C, Johnson K, McNamara G, Pileggi A, Molano RD, Reiser J, Tryggvason K, Kerjaschki D, Berggren PO, Mundel P, Ricordi C: Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release. Diabetes 59: 190–199, 2010.
24. Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI: Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant 29: 587–594, 2014.